Compare GKOS & PRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GKOS | PRM |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | United States |
| Employees | N/A | 371 |
| Industry | Medical/Dental Instruments | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.9B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | PRM |
|---|---|---|
| Price | $102.43 | $32.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $126.92 | $27.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.32 | $30.45 |
| Revenue Next Year | $27.43 | $8.44 |
| P/E Ratio | ★ N/A | $51.56 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $12.00 |
| 52 Week High | $148.11 | $34.89 |
| Indicator | GKOS | PRM |
|---|---|---|
| Relative Strength Index (RSI) | 28.38 | 55.88 |
| Support Level | $92.38 | $25.20 |
| Resistance Level | $102.80 | $34.89 |
| Average True Range (ATR) | 7.36 | 1.52 |
| MACD | -4.94 | -0.30 |
| Stochastic Oscillator | 1.08 | 35.48 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the company's retardant and foam products. The Specialty Products segment develops, produces, and markets phosphorus pentasulfide (P2S5)-based products used in lubricant additives, as well as in pesticide, mining chemical, and battery applications.